HLA-A2-Restricted Glioma Antigen-Peptide Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLA-A2-Restricted Glioma Antigen-Peptide Vaccine, covering 2015-12-08 to 2015-12-08. Get the full timeline:
Most recent: Clinical Trial Update: HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas [EARLY_Phase 1]